Corporate profile
Milestones
Our Philosophy
Management Team
Board of directors
Our mission
Targets and Strategies
Awards and Achievements
Rheumatic Specialty Prescription Western Pharmaceuticals
Other Pharmaceuticals
Pharmaceutical industry information
Rheumatism Industry Overview
Academy Frontier
Subject News
Product Information
Rheumatology
Common Rheumatism
Other rheumatism
Financial Highlights
Corporate Governance
Financial Reports
Prospectus
Announcements & Notices
Returns on Share Capital
Company Presentations
IR Calendar
IR Contact
Lansen Staff
Jobs
Home
>
Investor Relations
>
Announcements & Notices
2011-10-26
VOLUNTARY ANNOUNCEMENT - LANSEN SIGNS EXCLUSIVE MARKETING AND DISTRIBUTION AGREEMENT WITH ETHYPHARM FOR KETOPROFEN/OMEPRAZOLE SR IN THE PRC
2011-09-06
LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM
2011-09-06
LETTER TO SHAREHOLDERS AND CHANGE REQUEST FORM
2011-09-06
LETTER TO NEW SHAREHOLDERS AND REPLY FORM
2011-09-06
NOTIFICATION OF PUBLICATION OF 2011 INTERIM REPORT
2011-08-25
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2011
2011-08-12
DATE OF BOARD MEETING
2011-04-28
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 APRIL 2011
2011-03-25
LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM
2011-03-25
LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM
2011-03-25
LETTER TO NEW SHAREHOLDERS AND REPLY FORM
2011-03-25
NOTIFICATION OF PUBLICATION OF CORPORATE COMMUNCIATIONS ON THE COMPANY'S WEBSITE
2011-03-25
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 28 APRIL 2011
2011-03-25
NOTICE OF ANNUAL GENERAL MEETING
2011-03-25
PROPOSAL FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SHARES, AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
34
1/3
1
2
3
Next
...3
Copyright © 2005-2012 Lansen
Corporate profile
|
Legal Notices
|
Contact Us
|
Professional Link
Members of Lansen Holdings
Lansen Holdings
Ningbo Plant Extract
As with all prescription drugs, please follow your doctor's instructions